Skip to main content

Medication Treatments

A Canadian company has acquired the drug development program for a derivative of ibogaine, a potential treatment for opioid addiction.
CODAC Behavioral Healthcare is piloting a mobile treatment unit that is bringing medical care, counseling and referral guidance to high-need communities.
A report from the American Medical Association and Manatt Health suggests that Medicaid expansion states have a significant advantage in combating the opioid epidemic.
Cannabidiol (CBD) is being touted as an elixir for pain and numerous other ills. Amid the claims, addiction treatment patients are starting to seek guidance from their clinicians.
A Boston Medical Center study found that a more symptom-driven approach to treating infants with neonatal opioid withdrawal syndrome reduced hospital stays and use of agonist medication.
Back to Top